Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M867Revenue $M287Net Margin (%)-11.6Altman Z-Score11.4
Enterprise Value $M772EPS $-1.0Operating Margin %-11.8Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.3Pre-tax Margin (%)-11.9Higher ROA y-yN
Price/Book6.210-y EBITDA Growth Rate %--Quick Ratio3.4Cash flow > EarningsY
Price/Sales3.05-y EBITDA Growth Rate %--Current Ratio3.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-17.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-23.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M33.0ROIC % (ttm)-91.5Gross Margin Increase y-yN

Gurus Latest Trades with GHDX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GHDXDavid Swensen 2013-03-31 Sold Out -2.8%$26.72 - $29.65
($28.5)
$ 26.28-8%Sold Out0
GHDXDavid Swensen 2012-12-31 Buy 2.8%$26.42 - $36.8
($30.13)
$ 26.28-13%New holding37,861
GHDXDavid Swensen 2011-03-31 Sold Out -0.93%$21.08 - $26.18
($23.29)
$ 26.2813%Sold Out0
GHDXDavid Swensen 2010-12-31 Buy 0.93%$13.18 - $23.52
($17.74)
$ 26.2848%New holding38,243
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GHDX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


GHDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Vaughn James JChief Commercial Officer 2016-02-09Sell3$28-6.14view
LIVINGSTON RANDALL SDirector 2016-01-13Sell1,250$32.14-18.23view
Cole G BradleyCOO 2016-01-12Sell4,000$31.69-17.07view
Vaughn James JChief Commercial Officer 2016-01-07Sell2,000$33.63-21.86view
Cole G BradleyCOO 2015-12-08Sell4,000$29.26-10.18view
Leber LauraChief Communication Officer 2015-12-07Sell4,200$29.33-10.4view
Vaughn James JChief Commercial Officer 2015-12-07Sell2,000$29.33-10.4view
Cole G BradleyCOO 2015-11-10Sell4,000$26.030.96view
Cole G BradleyCOO 2015-09-09Sell9,664$25.353.67view
Cole G BradleyCOO 2015-07-07Sell4,000$27.53-4.54view

Quarterly/Annual Reports about GHDX:

News about GHDX:

Articles On GuruFocus.com
CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares Jul 13 2012 
Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Mar 16 2011 
Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Mar 16 2011 
Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Mar 14 2011 
Genomic Health Inc. (GHDX) COO G Bradley Cole sells 2,500 Shares Mar 10 2011 
Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Feb 16 2011 
Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Feb 14 2011 
Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Jan 19 2011 

More From Other Websites
Genomic Health to Announce First Quarter 2016 Financial Results and Host Conference Call on... Apr 27 2016
Genomic Health, Inc. – Value Analysis (NASDAQ:GHDX) : April 8, 2016 Apr 08 2016
Genomic Health, Inc. breached its 50 day moving average in a Bullish Manner : GHDX-US : April 7,... Apr 07 2016
Genomic Health (GHDX): Moving Average Crossover Alert Apr 01 2016
Genomic Health: Bleak Q4 on Lower Margins, Higher Costs Mar 18 2016
Genomic's Oncotype DX Positive in 5-Year Breast Cancer Trial Mar 15 2016
Woman Says Cancer Test Company Fired Her For Having Cancer Mar 15 2016
GENOMIC HEALTH INC Financials Mar 15 2016
Hedge Funds Are Hoarding Shares of These 5 Small-Caps Mar 11 2016
Genomic Health Announces Five-year Outcomes from International 'PlanB' Study Demonstrating the... Mar 11 2016
GENOMIC HEALTH INC Files SEC form 10-K, Annual Report Mar 09 2016
German National Cancer Guidelines Distinguish Oncotype DX® as First and Only Multi-gene Breast... Mar 09 2016
Genomic Health Breast Cancer Assay Positive in PlanB Trial Mar 02 2016
Genomic Health to Present at the Cowen and Company 36th Annual Health Care Conference Mar 02 2016
Journal of Clinical Oncology Publishes Prospective Outcomes Results from Large International Trial... Mar 01 2016
GENOMIC HEALTH INC Files SEC form 8-K, Change in Directors or Principal Officers Feb 22 2016
Genomic Health, Inc. Earnings Analysis: Q4, 2015 By the Numbers Feb 12 2016
Genomic Health Q4 Loss Wider than Expected, Revenues Up Feb 11 2016
Edited Transcript of GHDX earnings conference call or presentation 10-Feb-16 9:30pm GMT Feb 11 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)